Picture of Nu Skin Enterprises logo

NUS — Nu Skin Enterprises News Story

0.000.00%
us flag iconLast trade - 00:00
Consumer DefensivesAdventurousSmall CapContrarian

NU Skin Enterprises Inc reports results for the quarter ended in December - Earnings Summary

* NU Skin Enterprises Inc  NUS.N  reported quarterly
adjusted
earnings of 15 cents​​ per share for the quarter ended in
December, lower than the same quarter last year, when the
company reported EPS of 89 cents.  The mean expectation of
four analysts for the quarter was for earnings of 28 cents per
share. Wall Street expected results to range from 24 cents to 33
cents per share.
    * Revenue fell 6.5% to $488.64 million from a year ago;
analysts
expected $476.39 million. 
    * NU Skin Enterprises Inc shares had fallen by 10.5% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 3% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the personal
products
peer group is also "hold"

Wall Street's median 12-month price target for NU Skin
Enterprises Inc is $20.50 
This summary was machine generated from LSEG data February 14 at
11:22 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      0.28           0.15           Missed
 Sep. 30 2023      0.62           0.56           Missed
 Jun. 30 2023      0.53           0.54           Beat
 Mar. 31 2023      0.33           0.37           Beat

Recent news on Nu Skin Enterprises

See all news